Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
Clinical trial NCT02858453 · UNKNOWN
Trial details
- NCT number
- NCT02858453
- Sponsor
- Aquinox Pharmaceuticals (Canada) Inc.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-01
- Primary completion
- 2018-08-01
- Enrollment
- 433
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.